Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Product NDC
- 42494-409
- 11-digit product format
- 424940409
- Labeler code
- 42494
- Product ID
- 42494-409_aa5bd77a-ca5f-4835-9a06-aa97483102d9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlordiazepoxide Hydrochloride and Clidinium Bromide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Cameron Pharmaceuticals, LLC
- Application
- NDA012750
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 1966-09-01
- Marketing end
- 0000-00-00
- Substance
- CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42494-409-01 | 42494040901 | 100 CAPSULE in 1 BOTTLE (42494-409-01) | 100 capsule | 1966-09-01 | 0000-00-00 | No | No | Current |